Brief

COVID-19 | Health Care Access & Coverage

FDA Restrictions on Mifepristone: Time for a Change?

Recent Studies Confirm Clinical and Cost Effectiveness for Medical Management of Early Miscarriage

By:
  • Janet Weiner, PhD, MD, Courtney A. Schreiber, MD, MPH